Vinge advised Cantargia on the deal. Cantargia AB (publ) secured a rights offering of approximately SEK 170 million. Cantargia develops antibody based therapies against the target...
You must be a Standard 1 Year member to access this content.
Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a directed share issue of SEK 184 million and a tender offer for...
You must be a Standard 1 Year member to access this content.
Vinge advised Active Biotech on the offering. Active Biotech AB (publ) (Nasdaq Stockholm) has carried out a rights issue of approximately SEK 51 million. Active Biotech...
You must be a Standard 1 Year member to access this content.
Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a partial tender offer for outstanding subordinated perpetual floating rate callable sustainable capital...
You must be a Standard 1 Year member to access this content.
Vinge advised Cantargia AB on the deal. Cantargia AB (publ) completed a directed share issue of approximately SEK 59 million (approx. $5.4 million) to a number of...
You must be a Standard 1 Year member to access this content.
Vinge advised SAGA Diagnostics in connection with the transaction. SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue...
You must be a Standard 1 Year member to access this content.
Vinge advised Infant Bacterial Therapeutics AB on the offering. Infant Bacterial Therapeutics AB (publ) completed its rights offering of approximately SEK 100 million. IBT is addressing...
You must be a Standard 1 Year member to access this content.
Vinge advised SiB Solutions on the deal. SiB Solutions have received a SEK50M investment from Scania Growth Capital II to support their product development and scaling....
You must be a Standard 1 Year member to access this content.
Vinge advised BHG Group AB on the deal. BHG Group AB has successfully carried out a directed new issue of 39,024,390 shares, at a subscription price...
You must be a Standard 1 Year member to access this content.
Vinge advised Aneo on the deal. Cirio advised Scandinavian Biogas. Aneo Renewables Holding AS (“Aneo”) has announced a mandatory cash tender offer for the shares in...
You must be a Standard 1 Year member to access this content.
Cirio advised Scandinavian Biogas Fuels International AB on the deal while Vinge advised Aneo. The board of directors of Scandinavian Biogas resolved, subject to subsequent approval...
You must be a Standard 1 Year member to access this content.
Vinge advised Active Biotech on the deal. Active Biotech AB (publ) (Nasdaq Stockholm) carried out a rights issue of approximately SEK 55 million. Active Biotech is a...
You must be a Standard 1 Year member to access this content.
